226 related articles for article (PubMed ID: 31921179)
1. Selective Engagement of FcγRIV by a M2e-Specific Single Domain Antibody Construct Protects Against Influenza A Virus Infection.
De Vlieger D; Hoffmann K; Van Molle I; Nerinckx W; Van Hoecke L; Ballegeer M; Creytens S; Remaut H; Hengel H; Schepens B; Saelens X
Front Immunol; 2019; 10():2920. PubMed ID: 31921179
[TBL] [Abstract][Full Text] [Related]
2. Hierarchical and Redundant Roles of Activating FcγRs in Protection against Influenza Disease by M2e-Specific IgG1 and IgG2a Antibodies.
Van den Hoecke S; Ehrhardt K; Kolpe A; El Bakkouri K; Deng L; Grootaert H; Schoonooghe S; Smet A; Bentahir M; Roose K; Schotsaert M; Schepens B; Callewaert N; Nimmerjahn F; Staeheli P; Hengel H; Saelens X
J Virol; 2017 Apr; 91(7):. PubMed ID: 28077656
[TBL] [Abstract][Full Text] [Related]
3. Bispecific T cell engaging antibody constructs targeting a universally conserved part of the viral M2 ectodomain cure and prevent influenza A virus infection.
Pendzialek J; Roose K; Smet A; Schepens B; Kufer P; Raum T; Baeuerle PA; Muenz M; Saelens X; Fiers W
Antiviral Res; 2017 May; 141():155-164. PubMed ID: 28257797
[TBL] [Abstract][Full Text] [Related]
4. Passively transferred M2e-specific monoclonal antibody reduces influenza A virus transmission in mice.
Kolpe A; Schepens B; Ye L; Staeheli P; Saelens X
Antiviral Res; 2018 Oct; 158():244-254. PubMed ID: 30179634
[TBL] [Abstract][Full Text] [Related]
5. Protection against multiple influenza A virus strains induced by candidate recombinant vaccine based on heterologous M2e peptides linked to flagellin.
Stepanova LA; Kotlyarov RY; Kovaleva AA; Potapchuk MV; Korotkov AV; Sergeeva MV; Kasianenko MA; Kuprianov VV; Ravin NV; Tsybalova LM; Skryabin KG; Kiselev OI
PLoS One; 2015; 10(3):e0119520. PubMed ID: 25799221
[TBL] [Abstract][Full Text] [Related]
6. Influenza type A virus escape mutants emerge in vivo in the presence of antibodies to the ectodomain of matrix protein 2.
Zharikova D; Mozdzanowska K; Feng J; Zhang M; Gerhard W
J Virol; 2005 Jun; 79(11):6644-54. PubMed ID: 15890902
[TBL] [Abstract][Full Text] [Related]
7. Multiple heterologous M2 extracellular domains presented on virus-like particles confer broader and stronger M2 immunity than live influenza A virus infection.
Kim MC; Lee JS; Kwon YM; O E; Lee YJ; Choi JG; Wang BZ; Compans RW; Kang SM
Antiviral Res; 2013 Sep; 99(3):328-35. PubMed ID: 23811283
[TBL] [Abstract][Full Text] [Related]
8. An influenza A virus vaccine based on an M2e-modified alphavirus.
Krishnavajhala HR; Williams J; Heidner H
Arch Virol; 2018 Feb; 163(2):483-488. PubMed ID: 29079954
[TBL] [Abstract][Full Text] [Related]
9.
Van den Hoecke S; Ballegeer M; Vrancken B; Deng L; Job ER; Roose K; Schepens B; Van Hoecke L; Lemey P; Saelens X
mBio; 2021 Aug; 12(4):e0074521. PubMed ID: 34253060
[TBL] [Abstract][Full Text] [Related]
10. Influenza A virus infection engenders a poor antibody response against the ectodomain of matrix protein 2.
Feng J; Zhang M; Mozdzanowska K; Zharikova D; Hoff H; Wunner W; Couch RB; Gerhard W
Virol J; 2006 Dec; 3():102. PubMed ID: 17150104
[TBL] [Abstract][Full Text] [Related]
11. [Immunogenicity of recombinant proteins including ectodomain of M2 influenza virus A].
Stepanova LA; Kovaleva AA; Potapchuk MV; Korotkov AV; Kupriianov VV; Blokhina EA; Kotliarov RIu; Tsybalova LM
Vopr Virusol; 2013; 58(3):21-5. PubMed ID: 24006628
[TBL] [Abstract][Full Text] [Related]
12. The Role of Matrix Protein 2 Ectodomain in the Development of Universal Influenza Vaccines.
Saelens X
J Infect Dis; 2019 Apr; 219(Suppl_1):S68-S74. PubMed ID: 30715367
[TBL] [Abstract][Full Text] [Related]
13. [Construction and immunogenicity of recombinant bacteriophage T7 vaccine expressing M2e peptides of avian influenza virus].
Xu H; Wang YW; Tang YH; Zheng QS; Hou JB
Bing Du Xue Bao; 2013 Jun; 29(4):376-81. PubMed ID: 23895000
[TBL] [Abstract][Full Text] [Related]
14. Formatted single-domain antibodies can protect mice against infection with influenza virus (H5N2).
Tillib SV; Ivanova TI; Vasilev LA; Rutovskaya MV; Saakyan SA; Gribova IY; Tutykhina IL; Sedova ES; Lysenko AA; Shmarov MM; Logunov DY; Naroditsky BS; Gintsburg AL
Antiviral Res; 2013 Mar; 97(3):245-54. PubMed ID: 23274623
[TBL] [Abstract][Full Text] [Related]
15. Induction of influenza type A virus-specific resistance by immunization of mice with a synthetic multiple antigenic peptide vaccine that contains ectodomains of matrix protein 2.
Mozdzanowska K; Feng J; Eid M; Kragol G; Cudic M; Otvos L; Gerhard W
Vaccine; 2003 Jun; 21(19-20):2616-26. PubMed ID: 12744898
[TBL] [Abstract][Full Text] [Related]
16. Vaccination of pigs with a DNA construct expressing an influenza virus M2-nucleoprotein fusion protein exacerbates disease after challenge with influenza A virus.
Heinen PP; Rijsewijk FA; de Boer-Luijtze EA; Bianchi ATJ
J Gen Virol; 2002 Aug; 83(Pt 8):1851-1859. PubMed ID: 12124449
[TBL] [Abstract][Full Text] [Related]
17. The Antiviral Mechanism of an Influenza A Virus Nucleoprotein-Specific Single-Domain Antibody Fragment.
Hanke L; Knockenhauer KE; Brewer RC; van Diest E; Schmidt FI; Schwartz TU; Ploegh HL
mBio; 2016 Dec; 7(6):. PubMed ID: 27965447
[TBL] [Abstract][Full Text] [Related]
18. Universal vaccine based on ectodomain of matrix protein 2 of influenza A: Fc receptors and alveolar macrophages mediate protection.
El Bakkouri K; Descamps F; De Filette M; Smet A; Festjens E; Birkett A; Van Rooijen N; Verbeek S; Fiers W; Saelens X
J Immunol; 2011 Jan; 186(2):1022-31. PubMed ID: 21169548
[TBL] [Abstract][Full Text] [Related]
19. Structure of the extracellular domain of matrix protein 2 of influenza A virus in complex with a protective monoclonal antibody.
Cho KJ; Schepens B; Seok JH; Kim S; Roose K; Lee JH; Gallardo R; Van Hamme E; Schymkowitz J; Rousseau F; Fiers W; Saelens X; Kim KH
J Virol; 2015 Apr; 89(7):3700-11. PubMed ID: 25609808
[TBL] [Abstract][Full Text] [Related]
20. A bispecific antibody recognizing influenza A virus M2 protein redirects effector cells to inhibit virus replication in vitro.
Fernandez-Sesma A; Schulman JL; Moran TM
J Virol; 1996 Jul; 70(7):4800-4. PubMed ID: 8676511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
